Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM

K-Number: K022329 · 2002-11-27

ApplicantBayer Diagnostics Corp.
Decision Date2002-11-27
Product CodeLTK
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Bayer Diagnostics Corp.. It received FDA 510(k) clearance on 2002-11-27 under 510(k) number K022329. The device is classified under product code LTK. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM?

CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM is a medical device that received FDA 510(k) clearance on 2002-11-27. The listed applicant is Bayer Diagnostics Corp.. The 510(k) number is K022329.

When did CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM receive FDA 510(k) clearance?

CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM received FDA 510(k) clearance on 2002-11-27, under 510(k) number K022329.

Who is the listed applicant for CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM?

The FDA 510(k) record lists Bayer Diagnostics Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM?

The FDA product code for CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM is LTK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bayer Diagnostics Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K033379BAYER SPECIAL CHEMISTRY CONTROLSK033380BAYER SPECIAL CHEMISTRY CALIBRATORSK033007BAYER ADVIA DIGOXIN ASSAY FOR THE INTEGRATED MODULE SYSTEMK031857ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAYK022096URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMK030452BAYER LIGAND PLUS 1, 2, 3 CONTROLS

View all 32 devices →

Related Devices (Code: LTK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K240479Access OV MonitorBeckman Coulter, Inc.K213510IMMULITE/IMMULITE 1000 OM-MA, IMMULITE 2000 OM-MASiemens Healthcare Diagnostics Products, Ltd.K221355VITROS Immuodiagnostic Products CA 125 II Reagent PackOrtho Clinical DiagnosticsK200199ADVIA Centaur CA 125IISiemens Healthcare Diagnostics, Inc.K100321DIMENSION VISTA LOCI CA 125 FLEX REAGENT CARTRIDGE,AND DIMENSIONS VISTA LOCI 6 CAL, MODEL#'S K6455, AND KC604Siemens Healthcare DiagnosticsK080469VIDAS CA 15-3 ASSAYbioMerieux, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑